The critical role of risk-benefit assessments in cancer prevention.
Hawk
Ernest
E
Viner
Jaye L
JL
D016588:Anticarcinogenic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D015507:Drugs, Investigational / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000517:prevention & control*
D016588:Anticarcinogenic Agents; D015507:Drugs, Investigational